Roivant holder plans $10.3M stock sale Aug. 17

Rhea-AI Filing Summary

An affiliate of ROIV filed a Form 144 indicating an intention to sell 284,707 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on August 17, 2026, in connection with an Exercise of Options Under a Registered Plan, for an aggregate value of $10,320,571.81.

The filer, Mayukh Sukhatme, also reports prior open-market sales of ROIV common stock during the preceding three months: 500,000 shares for $17,051,141.93 on June 25, 2026, 500,000 shares for $17,039,650.00 on June 26, 2026, and 243,177 shares for $8,809,767.72 on August 14, 2026.

Key Figures

Shares to be sold: 284,707 shares Proposed sale value: $10,320,571.81 Sale June 25, 2026: 500,000 shares for $17,051,141.93 +2 more

5 metrics

Shares to be sold 284,707 shares Planned sale of ROIV common stock on August 17, 2026 under Form 144

Proposed sale value $10,320,571.81 Aggregate market value for 284,707 ROIV shares to be sold

Sale June 25, 2026 500,000 shares for $17,051,141.93 Past three months’ ROIV common stock sale by Mayukh Sukhatme

Sale June 26, 2026 500,000 shares for $17,039,650.00 Past three months’ ROIV common stock sale by Mayukh Sukhatme

Sale August 14, 2026 243,177 shares for $8,809,767.72 Past three months’ ROIV common stock sale by Mayukh Sukhatme

Key Terms

Form 144, Exercise of Options Under a Registered Plan, Executive Financial Services

3 terms

Form 144 regulatory

"144: Securities To Be Sold Common | 08/17/2026 | Exercise"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Options Under a Registered Plan financial

"Common | 08/17/2026 | Exercise of Options Under a Registered Plan | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ROIV disclose about upcoming share sales?

The Form 144 discloses a proposed sale of 284,707 ROIV common shares on August 17, 2026, tied to an Exercise of Options Under a Registered Plan, with an indicated aggregate value of $10,320,571.81 through Morgan Stanley Smith Barney LLC.

Who is the selling security holder in the ROIV Form 144 filing?

The selling security holder is Mayukh Sukhatme, listed with an address at 7th Floor, 50 Broadway, London. The filing details both the proposed sale on August 17, 2026 and several prior sales of ROIV common stock during the past three months.

How many ROIV shares has Mayukh Sukhatme sold in the past three months?

Over the past three months, Mayukh Sukhatme reports selling 1,243,177 ROIV common shares: 500,000 shares on June 25, 2026, 500,000 on June 26, 2026, and 243,177 on August 14, 2026, for stated aggregate proceeds in the tens of millions of dollars.

What proceeds were reported from recent ROIV share sales by Mayukh Sukhatme?

Reported proceeds include $17,051,141.93 on June 25, 2026, $17,039,650.00 on June 26, 2026, and $8,809,767.72 on August 14, 2026, all from sales of ROIV common stock, according to the past three months’ sales section.

What is the nature of the ROIV shares to be sold under this Form 144?

The shares to be sold are ROIV common stock to be issued upon Exercise of Options Under a Registered Plan. The planned transaction on August 17, 2026 is indicated as a cash exercise, with Morgan Stanley Smith Barney LLC Executive Financial Services listed as broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 04:40 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001750050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD.
SEC File Number	001-40782
Address of Issuer	7th Floor 50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	44 207 400 3347
Name of Person for Whose Account the Securities are To Be Sold	MAYUKH SUKHATME
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	284707	10320571.81	722323015	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Exercise of Options Under a Registered Plan	Issuer			284707	08/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	08/14/2026	243177	8809767.72
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/26/2026	500000	17039650.00
Mayukh Sukhatme 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/25/2026	500000	17051141.93

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mayukh Sukhatme
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)